LongeVC Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 11

Professionals

  • Investments
  • 30

  • Portfolio
  • 21

  • Exits
  • 7

Exits

LongeVC General Information

Company Description

Founded in 2020, LongeVC operates as a venture capital firm headquartered in Washington, D.C. The Firm invests early in regenerative medicine, AI for drug discovery, and breakthroughs in cancer, neurodegenerative, metabolic, and cardiovascular disease to advance clinically-validated interventions and cutting-edge science and technology to extend human healthspan.

Business Details

Website
www.longevc.com
Year Founded
2020
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Corporate Office
  • 2001 L Street North West
  • Suite 500
  • Washington, DC 20036
  • United States
+1 (561)

LongeVC Investments (30)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
SiPhox Health 09-Sep-2026 Later Stage VC Diagnostic Equipment Generating Revenue
Red Queen Bio 01-Jan-2026 Biotechnology Generating Revenue
Valink Therapeutics 20-Oct-2025 Drug Discovery Pre-Clinical Trials
Trogenix 06-Oct-2025 Drug Discovery Pre-Clinical Trials
Freedom Biosciences 01-Mar-2025 Drug Discovery Clinical Trials - General
PreComb 30-Dec-2024 Discovery Tools (Healthcare) Generating Revenue
Proton Intelligence 24-Dec-2024 Monitoring Equipment Generating Revenue
CatenaBio 20-Dec-2024 Drug Discovery Pre-Clinical Trials
Constructive Bio 04-Sep-2024 Early Stage VC Biotechnology Generating Revenue
Rubedo 25-Jul-2024 Later Stage VC Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 30 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LongeVC Exits (7)

Company Name Exit Date Exit Type Exit Size
Turn Biotechnologies 21-May-2026 Merger/Acquisition
InSilico Medicine Cayman 30-Dec-2025
Cidrani 02-Dec-2025
Basepaws 21-Jun-2022
Petsensus 21-Jan-2021 Bankruptcy: Liquidation
Deep Longevity 14-Dec-2020 Merger/Acquisition
You’re viewing 6 of 7 exits. Get the full list »

LongeVC Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

LongeVC FAQs

  • What is LongeVC?

    Founded in 2020, LongeVC operates as a venture capital firm headquartered in Washington, D.

  • When was LongeVC founded?

    LongeVC was founded in 2020.

  • Where is LongeVC headquartered?

    LongeVC is headquartered in Washington, DC.

  • What is LongeVC's total asset value?

    LongeVC has around in total assets under management.

  • How many investments has LongeVC made?

    LongeVC has made 30 investments.

  • What has LongeVC invested in?

    LongeVC has made numerous investments in companies like SiPhox Health, Red Queen Bio, and Valink Therapeutics within the Diagnostic Equipment, Biotechnology, and Drug Discovery industries.

  • What has LongeVC invested in recently?

    LongeVC's latest investment was on 09-Sep-2026 in SiPhox Health, a company within the Diagnostic Equipment industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process